Medivation, Inc. MDVN-Financial and Strategic SWOT Analysis Review

Medivation, Inc. MDVN-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH66457FSA
  • |
  • Pages: 56
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Medivation, Inc. (MDVN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Medivation, Inc. (Medivation) is a biopharmaceutical company which develops and commercializes medically innovative therapies to treat serious diseases. The company's only product XTANDI developed for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). The company with collaboration with Astellas conducts studies for the treatment of enzalutamide in prostate cancer, advanced breast cancer, and hepatocellular carcinoma. The company offers its product to pharmaceuticals, biotechnology drugs and medical devices. It operates along with its subsidiaries in the US and in the UK. Medivation is headquartered in San Francisco, California, the US.

Medivation, Inc. Key Recent Developments

Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation's Board

Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation's Board of Directors

May 27, 2016: Medivation Files Preliminary Consent Revocation Statement

May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation's Board

May 05, 2016: Sanofi Sends Letter to Medivation's Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Medivation, Inc.-Key Facts 6

Medivation, Inc.-Key Employees 7

Medivation, Inc.-Key Employee Biographies 8

Medivation, Inc.-Major Products and Services 9

Medivation, Inc.-Pharmaceutical Pipeline Products Data 10

Medivation, Inc., Pipeline Products by Therapy Area 10

Medivation, Inc., Pipeline Products by Development Phase 11

Medivation, Inc.-History 13

Medivation, Inc.-Company Statement 16

Medivation, Inc.-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Section 2-Company Analysis 19

Medivation, Inc.-Business Description 19

Medivation, Inc.-Corporate Strategy 20

Medivation, Inc.-SWOT Analysis 21

SWOT Analysis-Overview 21

Medivation, Inc.-Strengths 21

Strength-Collaboration With Astellas 21

Strength-Lead Product: Xtandi 21

Strength-Research and Development 21

Medivation, Inc.-Weaknesses 23

Weakness-Dependence on Third Party Manufacturers 23

Weakness-Termination of Development Programs 23

Medivation, Inc.-Opportunities 24

Opportunity-Acquisition of Talazoparib Product 24

Opportunity-Prostate Cancer Market 24

Opportunity-Strategic Partnerships 24

Medivation, Inc.-Threats 25

Threat-Competitive Environment 25

Threat-Stringent Government Regulations 25

Threat-Uncertain R&D outcomes 25

Medivation, Inc.-Key Competitors 26

Section 3-Company Financial Ratios 27

Financial Ratios-Capital Market Ratios 27

Financial Ratios-Annual Ratios 28

Performance Chart 29

Financial Performance 29

Financial Ratios-Interim Ratios 30

Financial Ratios-Ratio Charts 31

Section 4-Company's Lifesciences Financial Deals and Alliances 32

Medivation, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 32

Medivation, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 33

Medivation, Inc., Recent Deals Summary 34

Section 5-Company's Recent Developments 35

Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation's Board 35

Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation's Board of Directors 36

May 27, 2016: Medivation Files Preliminary Consent Revocation Statement 37

May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation's Board 39

May 05, 2016: Sanofi Sends Letter to Medivation's Board 42

May 05, 2016: Medivation Reports First Quarter 2016 Financial Results 43

Mar 28, 2016: Jennifer Jarrett to Join Medivation as Chief Financial Officer 45

Feb 25, 2016: Medivation Reports Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Financial Guidance 46

Jan 11, 2016: Medivation Names Marion McCourt Chief Operating Officer 49

Nov 05, 2015: Medivation Reports Third Quarter 2015 Financial Results 50

Section 6-Appendix 52

Methodology 52

Ratio Definitions 52

About GlobalData 56

Contact Us 56

Disclaimer 56

List of Figures

Medivation, Inc., Pipeline Products by Therapy Area 10

Medivation, Inc., Pipeline Products by Development Phase 11

Medivation, Inc., Performance Chart (2011-2015) 29

Medivation, Inc., Ratio Charts 31

Medivation, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 32

Medivation, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 33

List of Tables

Medivation, Inc., Key Facts 6

Medivation, Inc., Key Employees 7

Medivation, Inc., Key Employee Biographies 8

Medivation, Inc., Major Products and Services 9

Medivation, Inc., Number of Pipeline Products by Therapy Area 10

Medivation, Inc., Number of Pipeline Products by Development Stage 11

Medivation, Inc., Pipeline Products By Therapy Area and Development Phase 12

Medivation, Inc., History 13

Medivation, Inc., Subsidiaries 18

Medivation, Inc., Key Competitors 26

Medivation, Inc., Ratios based on current share price 27

Medivation, Inc., Annual Ratios 28

Medivation, Inc., Interim Ratios 30

Medivation, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 32

Medivation, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 33

Medivation, Inc., Recent Deals Summary 34

Currency Codes 52

Capital Market Ratios 52

Equity Ratios 53

Profitability Ratios 53

Cost Ratios 54

Liquidity Ratios 54

Leverage Ratios 55

Efficiency Ratios 55

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Tokai Pharmaceuticals, Inc.

Tesaro, Inc.

Pfizer Inc.

Orion Oyj

GTx, Inc.

Aragon Pharmaceuticals, Inc.

Medivation, Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8044
Site License
USD 250 INR 16088
Corporate User License
USD 375 INR 24131

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com